NEW

SC Johnson Professional Launches New Healthcare Website

SC Johnson Professional has launched a new website for its healthcare portfolio, scjp.com/healthcare. SC Johnson Professional Healthcare products contribute to helping to slow the spread of infection within health care facilities, by implementing safety protocols that...

Hologic Debuts Documentary-Style Film Highlighting One Woman’s Breast Cancer Journey Timed to Breast Reconstruction Awareness Day

Global leader in women’s health partners with medical streaming platform, Mediflix, to provide first-of-its-kind awareness and education tool highlighting reconstructive options for breast cancer patients In conjunction with ongoing Breast Cancer Awareness Month...

New Preoperative Surgical Planning Product for Total Hip Arthroplasty

Intellijoint Surgical has announced a new preoperative surgical planning product for total hip arthroplasty. Intellijoint VIEW is a surgical planning software that provides targets for functional cup position accounting for hip-spine relationship and implant...

Fujifilm Launches First FDA Cleared Dual-Channel Endoscope for Upper and Lower Gastrointestinal Applications

Fujifilm will showcase its El-740D/S dual-channel endoscope at the American College of Gastroenterology convention in Las Vegas, October 22-27 FUJIFILM Healthcare Americas Corporation, a provider of endoscopic imaging and endosurgical solutions, has announced the...

New Data on OviTex in Hernia Repair Applications

TELA Bio, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, has announced details of the clinical research presented last week at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in Las Vegas, Nevada.

Two poster presentations revealed new data, while a third video presentation demonstrated a novel surgical technique that leverages the unique properties of OviTex® Reinforced Tissue Matrix.

Robotic Assisted ReBAR of 111 Inguinal Hernias, presented by Dr. Cory Banaschak, DO and Dr. Paul Szotek, MD, MBA, FACS, Medical Director of the Indiana Hernia Center, revealed a 2.7% recurrence rate, a 1.8% surgical site occurrence rate, and no infections in patients with at least one year of follow-up. The authors concluded that robotic transabdominal preperitoneal (rTAPP) inguinal hernia repair with OviTex presents a viable and more natural repair alternative in minimally invasive surgery, an approach typically reserved for permanent synthetic meshes. Dr. Szotek stated, “The Reinforced Biologic Augmented Repair, or the ReBAR technique, applies sound hernia surgery principles while leveraging the benefits of a reinforced biologic material with a low synthetic foreign body burden. Our initial goals in adopting OviTex were to lower recurrences while decreasing the amount of synthetic foreign body implanted. That’s what patients are increasingly looking for, and it makes a lot of clinical sense if you can achieve it. With over five years of experience utilizing the ReBAR technique with OviTex, it appears that we are on the way to achieving these goals.”

Additional data on hernia repairs performed by Drs. Szotek and Banaschak employing the ReBAR technique was recently highlighted in an article entitled, Minimizing Retained Foreign Body in Hernia Repair Using a Novel Technique: Reinforced Biologic Augmented Repair (ReBAR) published in the Journal of Clinical and Medical Research. In this prospective study of 619 implants using the ReBAR technique for a variety of open and minimally invasive inguinal and abdominal hernia repairs the authors reported an overall recurrence rate of 1.3%.

Use of Ovine Reinforced Tissue Matrix in Bridged Incisional Hernia Repair, presented by Dr. DeNoto III, MD, FACS, Director of General Surgery at St. Francis Hospital in New York, analyzed recurrence rates in the treatment of abdominal hernias that require reinforcement in the absence of a primary repair. “These are some of the most complex and challenging patients to reduce the potential of a future hernia recurrence,” said Dr. DeNoto. In this series, patients with bridged repairs using OviTex had a 14% recurrence rate. “To put the results of our study in perspective, at similar time points we have seen recurrence rates more than double when repaired with human or porcine mesh products. This is a major reason why patients presenting with bridged repairs are so difficult to treat and why an effective reinforcement option is much needed.”

For more information on the SAGES poster presentations, visit epostersonline.com/sages2021.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X